# DNS-3379 vs. Placebo in Stroke Rehabilitation

> **NCT03254160** · PHASE2 · TERMINATED · sponsor: **Dart NeuroScience, LLC** · enrollment: 1 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** DNS-3379
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03254160
- **Lead sponsor:** Dart NeuroScience, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-13
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Administrative
- **Last updated:** 2018-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03254160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03254160, "DNS-3379 vs. Placebo in Stroke Rehabilitation". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03254160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*